• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Darling Ingredients Inc.

    5/7/26 4:32:29 PM ET
    $DAR
    Packaged Foods
    Consumer Staples
    Get the next $DAR alert in real time by email
    S-8 1 d126183ds8.htm S-8 S-8

    As filed with the Securities and Exchange Commission on May 7, 2026

    Registration No. 333-   

     

     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    DARLING INGREDIENTS INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   36-2495346

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    5601 N. MacArthur Blvd.,

    Irving, Texas

      75038
    (Address of Principal Executive Offices)   (Zip Code)

    Darling Ingredients Inc. 2026 Omnibus Incentive Plan

    (Full title of the plan)

    Nick Kemphaus

    Executive Vice President, General Counsel and Secretary

    5601 N. MacArthur Blvd., Irving, Texas 75038

    (972)-717-0300

    (Name and address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     
     


    EXPLANATORY NOTE

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed by Darling Ingredients Inc., a Delaware corporation (the “Registrant”), relating to 5,645,450 shares of its common stock, par value $0.01 per share (the “Common Stock”), issuable under the Darling Ingredients Inc. 2026 Omnibus Incentive Plan (the “2026 Plan”).

    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    All information required by Part I to be contained in the prospectus is omitted from this Registration Statement in accordance with the explanatory note to Part I of Form S-8 and Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”). Documents containing the information required by Part I of the Registration Statement will be sent or given to the participant in the 2026 Plan as specified by Rule 428(b)(1) under the Securities Act.

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The following documents previously filed by the Registrant with the Securities and Exchange Commission (the “Commission”) are incorporated by reference into this Registration Statement:

     

    (1)

    The Registrant’s Annual Report on Form 10-K for the fiscal year ended January 3, 2026, filed with the Commission on March 3, 2026;

     

    (2)

    The Registrant’s Current Reports on Form 8-K, filed with the Commission on February 25, 2026; and

     

    (3)

    The description of the Common Stock contained in the Registrant’s Registration Statement on Form 8-A (Registration No. 001-13323), filed with the Commission on May  29, 2025, including Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended January 2, 2021, and including any amendment or report filed for the purpose of updating such description.

    All documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates of filing of such documents (such documents, and the documents enumerated above, being hereinafter referred to as “Incorporated Documents”).

    Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Notwithstanding the foregoing, unless specifically stated to the contrary, none of the information disclosed by the Registrant under Items 2.02 or 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, that the Registrant may from time to time furnish to the Commission will be incorporated by reference into, or otherwise included in, this Registration Statement.


    Item 4. Description of Securities.

    Not applicable.

    Item 5. Interests of Named Experts and Counsel.

    Nick Kemphaus who is providing the opinion of counsel in connection with this Registration Statement is an Executive Vice President, General Counsel of the Registrant and participates in the Registrant’s employee compensation programs.

    Item 6. Indemnification of Directors and Officers.

    Section 145 of the Delaware General Corporation Law (“Section 145”) permits indemnification of officers and directors of a corporation under certain conditions and subject to certain limitations. Section 145 also provides that a corporation has the power to maintain insurance on behalf of its officers and directors against any liability asserted against such person and incurred by him or her in such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify him or her against such liability under the provisions of Section 145.

    Article Eleven, Section 1, of the Registrant’s Amended and Restated Certificate of Incorporation (the “Certificate”) provides for mandatory indemnification of its directors and officers and permissible indemnification of employees and other agents to the maximum extent not prohibited by the Delaware General Corporation Law. The rights to indemnity thereunder continue as to a person who has ceased to be a director, officer, employee or agent and inure to the benefit of the heirs, executors and administrators of the person. In addition, expenses incurred by a director or executive officer in defending any civil, criminal, administrative or investigative action, suit, proceeding, arbitration, mediation or claim in respect thereof (collectively, “Actions”) by reason of the fact that he or she is or was a director or officer of the Registrant (or was serving at the Registrant’s request as a director or officer of another corporation) shall be paid by the Registrant in advance of the final disposition of such Action upon receipt of an undertaking by or on behalf of the director or officer to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the Registrant as authorized by the relevant section of the Delaware General Corporation Law.

    As permitted by Section 102(b)(7) of the Delaware General Corporation Law, the Certificate provides that, pursuant to Delaware law, the Registrant’s directors and officers shall not be personally liable for monetary damages for breach of the directors’ or officers’ fiduciary duty as directors or officers to the Registrant and its stockholders. This provision in the Certificate does not eliminate the directors’ or officers’ fiduciary duties, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director and officer will continue to be subject to liability for breach of the duty of loyalty to the Registrant, for acts or omission not in good faith or involving intentional misconduct, for knowing violations of law, and for any transactions from which the director or officer derived an improper personal benefit. In addition, directors will continue to be subject to liability for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Section 174 of the Delaware General Corporation Law. Officers will continue to be subject to liability for derivative claims on behalf of the Registrant by a stockholder.

    The Registrant has entered into indemnification agreements with each of its directors and executive officers and purchased directors’ and officers’ liability insurance. Generally, the indemnification agreements attempt to provide the maximum protection permitted by Delaware law as it may be amended from time to time. Moreover, the indemnification agreements provide for certain additional indemnification. Under such additional indemnification provisions, an individual will receive indemnification for expenses, judgments, fines and amounts paid in settlement if he or she is found to have acted in good faith and in a manner reasonably believed to be in, or not opposed to, the best interests of the Registrant, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. In addition, the Registrant will provide unsecured, interest-free advances for the expenses (including attorneys’ fees) incurred by any individual in defending against any threatened, pending or completed action, suit, demand, arbitration, alternate dispute resolution mechanism, investigation, inquiry,


    administrative hearing or any other actual, threatened or completed proceeding. Notwithstanding anything to the contrary in the indemnification agreement, the Registrant shall not indemnify any such director or executive officer seeking indemnification in connection with any action, suit, proceeding, claim or counterclaim, or part thereof, initiated by such person unless the initiation thereof was authorized in the specific case by the Board of Directors of the Registrant or the Registrant provides the indemnification, in its sole discretion, pursuant to the powers vested in the Registrant under applicable law.

    Item 7. Exemption from Registration Claimed.

    Not applicable.

    Item 8. Exhibits.

     

    Exhibit
    No.
     

    Description

      4.1   Amended and Restated Certificate of Incorporation of the Registrant, effective May  7, 2024 (filed as Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the Commission on August 7, 2024 and incorporated herein by reference).
      4.2   Amended and Restated Bylaws of the Registrant dated July  7, 2025 (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Commission on July 7, 2025 and incorporated herein by reference).
     *4.3   Darling Ingredients Inc. 2026 Omnibus Incentive Plan.
     *5.1   Opinion of Nick Kemphaus with respect to validity of issuance of securities.
    *23.1   Consent of Nick Kemphaus (included as part of Exhibit 5.1 hereto).
    *23.2   Consent of independent registered public accounting firm.
    *24.1   Powers of Attorney (included in the signature page to this Registration Statement).
    *107   Calculation of Filing Fee Table.

     

    *

    Filed herewith.

    Item 9. Undertakings.

    (a) The undersigned Registrant hereby undertakes:

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.


    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irving, State of Texas, on May 7, 2026.

     

    DARLING INGREDIENTS INC.
    By   /s/ Robert W. Day
    Name   Robert W. Day
    Title   Chief Financial Officer (Principal Financial Officer)

    KNOW ALL MEN BY THESE PRESENTS, that that each of the undersigned hereby constitutes and appoints, jointly and severally, Randall C. Stuewe, Robert W. Day, and Nick Kemphaus, or any of them (with full power to each of them to act alone), as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for him or her and on his or her behalf to sign, execute and file all amendments (including, without limitation, post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and any documents required to be filed with respect therewith, with the Commission or any regulatory authority, granting unto such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises in order to effectuate the same as fully to all intents and purposes as he or she might or could do if personally present, hereby ratifying and confirming all that such attorneys-in-fact and agents, or any of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done.

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.


    Signature

      

    Title

     

    Date

    /s/ Randall C. Stuewe

      

    Chairman of the Board and Chief Executive Officer

    (Principal Executive Officer)

      May 7, 2026
    Randall C. Stuewe

    /s/ Robert W. Day

      

    Chief Financial Officer

    (Principal Financial Officer)

      May 7, 2026
    Robert W. Day

    /s/ Joseph Manzi

      

    Chief Accounting Officer

    (Principal Accounting Officer)

      May 7, 2026
    Joseph Manzi

    /s/ Charles Adair

       Director   May 7, 2026
    Charles Adair

    /s/ Robert Aspell

       Director   May 7, 2026
    Robert Aspell

    /s/ Larry A. Barden

       Director   May 7, 2026
    Larry A. Barden

    /s/ Celeste A. Clark

       Director   May 7, 2026
    Celeste A. Clark

    /s/ Linda Goodspeed

       Director   May 7, 2026
    Linda Goodspeed

    /s/ Enderson Guimaraes

       Director   May 7, 2026
    Enderson Guimaraes

    /s/ Randy L. Hill

       Director   May 7, 2026
    Randy L. Hill

    /s/ Soren Schroder

       Director   May 7, 2026
    Soren Schroder

    /s/ Kurt Stoffel

       Director   May 7, 2026
    Kurt Stoffel
    Get the next $DAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DAR

    DatePrice TargetRatingAnalyst
    4/28/2026$58.00 → $72.00Buy
    TD Cowen
    2/13/2026$45.00 → $58.00Buy
    TD Cowen
    2/2/2026$62.00Neutral → Outperform
    Robert W. Baird
    12/2/2025$34.00 → $45.00Hold → Buy
    TD Cowen
    10/8/2025$45.00Buy
    BofA Securities
    8/20/2025$43.00Overweight
    Analyst
    7/25/2025$36.00Outperform → Neutral
    Robert W. Baird
    4/25/2025$37.00 → $34.00Hold
    TD Cowen
    More analyst ratings

    $DAR
    SEC Filings

    View All

    Darling Ingredients Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - DARLING INGREDIENTS INC. (0000916540) (Filer)

    5/11/26 8:01:11 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DARLING INGREDIENTS INC. (0000916540) (Filer)

    5/8/26 4:22:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by Darling Ingredients Inc.

    10-Q - DARLING INGREDIENTS INC. (0000916540) (Filer)

    5/8/26 4:18:07 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Hill Randy L was granted 3,351 shares, increasing direct ownership by 26% to 16,226 units (SEC Form 4)

    4/A - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    5/14/26 5:26:53 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Director Schroder Soren was granted 2,911 shares, increasing direct ownership by 29% to 13,086 units (SEC Form 4)

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    5/8/26 5:54:07 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Director Stoffel Kurt was granted 2,650 shares, increasing direct ownership by 14% to 21,139 units (SEC Form 4)

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    5/8/26 5:20:04 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Chief Admin Officer Mcnutt Patrick bought $51,805 worth of shares (1,300 units at $39.85), increasing direct ownership by 6% to 21,867 units (SEC Form 4)

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    8/19/24 4:21:03 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    EVP Chief Strategy Officer Day Robert W bought $99,685 worth of shares (2,532 units at $39.37), increasing direct ownership by 25% to 12,607 units (SEC Form 4)

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    8/1/24 6:41:37 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Jansen Matthew J bought $256,560 worth of shares (6,000 units at $42.76), increasing direct ownership by 9% to 74,065 units (SEC Form 4)

    4 - DARLING INGREDIENTS INC. (0000916540) (Issuer)

    3/5/24 5:52:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Darling Ingredients with a new price target

    TD Cowen reiterated coverage of Darling Ingredients with a rating of Buy and set a new price target of $72.00 from $58.00 previously

    4/28/26 6:53:40 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    TD Cowen reiterated coverage on Darling Ingredients with a new price target

    TD Cowen reiterated coverage of Darling Ingredients with a rating of Buy and set a new price target of $58.00 from $45.00 previously

    2/13/26 8:02:23 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Darling Ingredients from Neutral to Outperform and set a new price target of $62.00

    2/2/26 6:46:46 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Darling Ingredients' Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation

    Darling Ingredients Inc. (NYSE:DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide ingredient developed to help support healthy after-meal blood sugar levels, naturally. The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing blood glucose through science-backed nutrition. "This patent reinforces the scientific foundation behind Nextida GC and highlights Darling Ingredients' ability to translate its collagen expertise into targeted health solutions," s

    6/3/26 5:10:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Nevada's Only Refinery Just Got a Jet-Fuel Makeover Plan

    WOODS CROSS, Utah, June 02, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary — The U.S. refining map is getting smaller. West Coast capacity has been shrinking as older plants close, the major refiners spent the first quarter of 2026 emphasizing discipline over expansion, and the Trump administration has used Defense Production Act determinations to flag domestic refining as a strategic priority. Into that tightening backdrop, Sky Quarry Inc. (NASDAQ:SKYQ) — owner of the only operating refinery in the State of Nevada — has just signed an agreement aimed at turning that refinery toward one of the fastest-repricing corners of the fuel market: sustainable aviation fuel. It is an am

    6/2/26 8:45:00 AM ET
    $AMTX
    $DAR
    $GEVO
    Major Chemicals
    Industrials
    Packaged Foods
    Consumer Staples

    The Unlikely Intersection of America's Only Nevada Refinery and Sustainable Aviation Fuel

    Issued on behalf of Sky Quarry, Inc. A small-cap operator with a 5,000-bpd refinery just signed a multi-party MOU with two clean-fuel partners — and the move suggests the next chapter of the SAF investment cycle may be more vertically integrated than markets are pricing in NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — Markets often miss small-cap operators when they make moves that pre-date the consensus narrative. The U.S. sustainable aviation fuel investment cycle has been running for a few years now, and the consensus operators — Calumet's Montana Renewables, Diamond Green Diesel, Gevo's Net-Zero 1, Aemetis's California SAF facility — have been investing

    5/12/26 10:28:00 AM ET
    $AMTX
    $CLMT
    $DAR
    Major Chemicals
    Industrials
    Integrated oil Companies
    Energy

    $DAR
    Leadership Updates

    Live Leadership Updates

    View All

    JetBlue Announces First Regular Supply of Blended Sustainable Aviation Fuel (SAF) for Commercial Air Travel in New York

    JetBlue signs supply agreement for Blended Sustainable Aviation Fuel (SAF) to supply John F. Kennedy International Airport (JFK) to begin as early as fourth quarter 2024 JetBlue invites other New York businesses to help scale the SAF market in the region Today JetBlue (NASDAQ:JBLU) and World Fuel Services (World Fuel), a World Kinect (NYSE:WKC) company, announced a new commercial agreement to bring the first regular supply of Blended Sustainable Aviation Fuel (SAF), provided by Valero Marketing and Supply Company (Valero), a subsidiary of Valero Energy Corporation (NYSE:VLO), to John F. Kennedy International Airport (JFK) as early as the fourth quarter of 2024. Under the terms of the in

    7/31/24 8:17:00 AM ET
    $DAR
    $JBLU
    $VLO
    Packaged Foods
    Consumer Staples
    Air Freight/Delivery Services
    Consumer Discretionary

    Darling Ingredients Honored By The Women's Forum Of New York For Active Leadership To Attain Gender Parity On Its Corporate Board

    IRVING, Texas, Nov. 10, 2021 /PRNewswire/ -- Darling Ingredients Inc. (NYSE:DAR) is being honored by the Women's Forum of New York at its sixth biennial "Breakfast of Corporate Champions" (BCC) event, for achieving at least 35 percent female representation on their board of directors. Darling Ingredients is recognized as a corporate game-changer for promoting women's leadership in the boardroom, with 40 percent women representation on their board of directors. This is the third consecutive year Darling has received this prestigious recognition. "As an international organizati

    11/10/21 7:00:00 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients Inc. Announces New Appointment to Board of Directors

    IRVING, Texas, Oct. 26, 2021 /PRNewswire/ -- Darling Ingredients Inc. (NYSE:DAR) today announces the appointment of Celeste A. Clark, Ph.D., to its Board of Directors.  Dr. Clark joins the Board as an independent director, and her appointment is effective immediately.  The appointment of Dr. Clark will expand the total number of directors to ten.  It is expected that she will also be appointed to a new, standalone environmental, social and governance (ESG) committee currently being developed by the Board. Dr. Clark has served as a principal of Abraham Clark Consulting, LLC

    10/26/21 6:37:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Financials

    Live finance-specific insights

    View All

    Darling Ingredients Inc. Reports First Quarter 2026 Results

    Net income of $134.3 million, or $0.83 per GAAP diluted share, compared to net loss of $(26.2) million, or $(0.16) per GAAP diluted share for the first quarter 2025 Total net sales were $1.6 billion, compared to $1.4 billion for first quarter 2025 Combined Adjusted EBITDA was $406.8 million, compared to $195.8 million for first quarter 2025 Monetized $45.0 million of Production Tax Credit sales during the first quarter of 2026 Darling Ingredients Inc. (NYSE:DAR) today reported net income of $134.3 million or $0.83 per diluted share for the first quarter of 2026, compared to a net loss of $(26.2) million, or $(0.16) per diluted share, for the first quarter of 2025. The company a

    4/30/26 6:34:00 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients Inc. to Release First Quarter 2026 Financial Results

    Darling Ingredients Inc. (NYSE:DAR) announced today that it will host a conference call on Thursday, April 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors. To access the call as a listener, please register for the audio-only webcast. To join the call as a participant to ask a question, please register in advance to receive a confirmation email with the dial-in number and PIN for immediate access on April 30 or call 833-470-1428 (United St

    4/16/26 4:35:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    Darling Ingredients Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

    Fourth Quarter Highlights Net income of $56.9 million, or $0.35 per GAAP diluted share, compared to $101.9 million for fourth quarter 2024, or $0.63 per GAAP diluted share Total net sales were $1.7 billion, compared to $1.42 billion for fourth quarter 2024 Combined Adjusted EBITDA was $336.1 million, compared to $289.5 million for fourth quarter 2024 Fiscal Year Highlights Net income of $62.8 million, or $0.39 per GAAP diluted share, compared to $278.9 million for fiscal year 2024, or $1.73 per GAAP diluted share Total net sales were $6.1 billion, compared to $5.7 billion for fiscal year 2024 Combined Adjusted EBITDA was $1.03 billion, compared to $1.08 billion for fisc

    2/11/26 4:45:00 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Darling Ingredients Inc. (Amendment)

    SC 13G/A - DARLING INGREDIENTS INC. (0000916540) (Subject)

    2/13/24 5:02:32 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Darling Ingredients Inc. (Amendment)

    SC 13G/A - DARLING INGREDIENTS INC. (0000916540) (Subject)

    2/9/23 11:16:32 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Darling Ingredients Inc. (Amendment)

    SC 13G/A - DARLING INGREDIENTS INC. (0000916540) (Subject)

    2/9/23 9:59:38 AM ET
    $DAR
    Packaged Foods
    Consumer Staples